Intervention of Interest
- brensocatib (Insmed Pharmaceuticals)
For questions please contact info@icer.org.
View the Key Stakeholder List.
Assessment Status
Open
Upcoming Milestone
Revised Scoping DocumentView
Intervention of Interest
For questions please contact info@icer.org.
View the Key Stakeholder List.
CTAF
The CTAF’s 2025 public meeting on brensocatib
Public Comment Period
See Full TimelinePlease find the research protocol here:
Public Comments
OpenView
Closed